Latest filing published 04 Oct 2013 for Aveo Pharmaceuticals, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ngoc Tuan Ha: trading record in brief
Ngoc Tuan Ha is a declared insider at 2 companies; the most frequent names are Aveo Pharmaceuticals, Inc. and Human Genome Sciences Inc. In total, 47 filings cover trades dated from 18 December 2009 to 2 October 2013.
The open-market side counts 7 purchases for €715k alongside 6 sales for €391k. Taken together, the purchases exceed the sales by €324k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 16 share grants and 6 option exercises.
In size, the median ticket on the buying side is €74k.
On 4 October 2013 came the latest disclosure, a transaction in Aveo Pharmaceuticals, Inc. The last insider purchase was made public on 14 December 2012, 5,077 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ngoc Tuan Ha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 118,187 shares0Common StockSEC:0001181431-13-052544:0
- 118,187 shares0Common StockSEC:0001181431-13-052544:1
- 137,500 shares0Common StockSEC:0001181431-13-052544:2
- 82,500 shares0Common StockSEC:0001181431-13-005177:0
- 33,793 shares0Common StockSEC:0001181431-12-064662:0
- 33,793 shares0Common StockSEC:0001181431-12-064662:1
- 60,900 shares@ US$6.61Common StockSEC:0001181431-12-064662:2Canonical exit: 12 Mar 2013 (T+90)
- 14,100 shares@ US$6.85Common StockSEC:0001181431-12-064662:3Canonical exit: 13 Mar 2013 (T+90)
- 16,807 shares@ US$14.25Common StockSEC:0001225208-12-016974:1
- 462 shares@ US$13.64Common StockSEC:0001225208-12-016144:0
- 2,500 shares0Common StockSEC:0001225208-12-012853:0
- 755 shares@ US$7.53Common StockSEC:0001225208-12-009670:0
- 50,000 shares@ US$0.48Common StockSEC:0001181431-12-010451:0
- 55,000 shares0Common StockSEC:0001181431-12-005357:0
- 18,349 shares0Common StockSEC:0001181431-12-004490:0
- 18,349 shares0Common StockSEC:0001181431-12-004490:1
- 4,613 shares@ US$13.37Common StockSEC:0001181431-12-004490:2
- 739 shares@ US$8.03Common StockSEC:0001225208-12-001232:0
- 376 shares@ US$11.13Common StockSEC:0001225208-11-023257:0
- 10,000 shares@ US$16.00Common StockSEC:0001225208-11-019413:0Canonical exit: 3 Nov 2011 (T+90)
- 160 shares@ US$24.52Common StockSEC:0001225208-11-018060:0
- 7,000 shares@ US$2.00Common StockSEC:0001181431-11-039277:0
- 7,000 shares@ US$20.27Common StockSEC:0001181431-11-039277:1
- 7,000 shares@ US$2.00Common StockSEC:0001181431-11-034794:0
- 7,000 shares@ US$18.52Common StockSEC:0001181431-11-034794:1
25 of 45 declarations
